http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008072338-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65462346110f88b24c5d3207a37ef12c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-035
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-00
filingDate 2005-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b51ebc9602ea54d9584d93dca8792b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de74bcbe46fc3e1041bbf9e888d737a7
publicationDate 2008-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2008072338-A1
titleOfInvention Animal for Drug Efficacy Evaluation, Method for Developing Chronic Obstructive Pulmonary Disease in Animal for Drug Efficacy Evaluation, and Method for Evaluating Drug Efficacy Using the Animal
abstract The present invention provides an animal for drug efficacy evaluation produced by administering an aqueous solution, in which cigarette smoke is dissolved in water or physiological saline, directly to a lower airway of an animal except a human so as to develop chronic obstructive pulmonary disease; a method for developing chronic obstructive pulmonary disease in an animal for drug efficacy evaluation including administering an aqueous solution, in which cigarette smoke is dissolved in water or physiological saline, directly to a lower airway of an animal except a human; and a method for evaluating drug efficacy including administering a drug to the animal for drug efficacy evaluation and then evaluating the effect of the drug.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008133861-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8541645-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011099645-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106770246-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109601471-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109601472-A
priorityDate 2004-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5850840-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4289128-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4502482-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6270747-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9598
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9598
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451370915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159937042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9793

Total number of triples: 33.